Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment
- 15 January 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (2), 545-552
- https://doi.org/10.1182/blood-2003-05-1558
Abstract
Knowledge of the composition and inter- relationship of the various hematopoietic stem cells (HSCs) that comprise the hu- man HSC pool and the consequence of culture on each class is required for effec- tive therapies based on stem cells. Clonal tracking of retrovirally transduced HSCs in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice re- vealed heterogeneity in the repopulation capacity of SCID-repopulating cells (SRCs). However, it is impossible to estab- lish whether HSC heterogeneity is intrin- sic or whether the culture conditions re- quired for retroviral transduction induce qualitative and quantitative alterations to SRCs. Here, we report establishment of a clonal tracking method that uses lentivec- tors to transduce HSCs with minimal ma- nipulation during overnight culture with- out cytokine stimulation. By serial bone marrow (BM) sampling of mice receiving transplants, short-term SRCs (ST-SRCs) and long-term SRCs (LT-SRCs) were iden- tified on the basis of repopulation dynam- ics demonstrating that their existence is not an experimental artifact but reflects the state of the HSC pool. However, 4 days of culture in conditions previously used for SRC retroviral transduction sig- nificantly reduced SRC number as as- sessed by clonal analysis. These studies provide a foundation to understand the molecular and cellular determinants of human HSC development and to develop therapies targeted to specific HSC classes. (Blood. 2004;103:545-552)Keywords
This publication has 49 references indexed in Scilit:
- Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID miceBlood, 2002
- Molecular Evidence of Lentiviral Vector-Mediated Gene Transfer into Human Self-Renewing, Multi-potent, Long-Term NOD/SCID Repopulating Hematopoietic CellsMolecular Therapy, 2002
- Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesisBlood, 2002
- Haematopoietic stem cells1The Journal of Pathology, 2002
- Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-β2 microglobulin–null miceJCI Insight, 2001
- The Human Sheep Xenograft Model for the Study of the In Vivo Potential of Human HSC and In Utero Gene TransferThe International Journal of Cell Cloning, 2000
- CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimensBone Marrow Transplantation, 1997
- Cytokine Stimulation of Multilineage Hematopoiesis from Immature Human Cells Engrafted in SCID MiceScience, 1992
- Engraftment of Immune-Deficient Mice with Human Hematopoietic Stem CellsScience, 1988